Search

everythinglearnresearchcommunity

for

Search:↓

Microneedle patches could replace injections but need more development for better use in medicine.

Vitiligo and alopecia areata may have similar causes despite their differences.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Environmental health research must address racism to improve health outcomes for BIPOC communities.

Understanding fibroblast issues in diabetic foot ulcers is key to creating better treatments.

Hair becomes gray and thin as we age, and while most hair loss in older people is due to genetics, there's a chance for gray hair to regain color under certain conditions.

Male infertility and genitourinary birth defects are often linked to genetic issues.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Single-cell encapsulation shows promise for medical use but faces production challenges.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

Alopecia areata may be linked to scalp microbiome differences, suggesting potential treatments with prebiotics, probiotics, and postbiotics.

Myhre syndrome symptoms worsen over time, with specific genetic variants affecting severity.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Prevent lower extremity arterial ulcers by screening for risk factors, using medical treatments, and involving interdisciplinary care.

The DLQI is a key tool for measuring quality of life in dermatology.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

HIV symptoms often occur together and cause similar distress.

Lower Gas6 and sAxl levels are linked to hair loss in COVID-19 survivors.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

The surrounding tissue plays a crucial role in the growth and spread of skin cancer.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

CNVs influence hair length in Tianzhu white yaks.

The conclusion suggests a new acne treatment that controls bacteria by reducing water in the skin's pores using sugar-like substances.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.